243 related articles for article (PubMed ID: 33330092)
1. BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer
Zhao S; Xue H; Hao CL; Jiang HM; Zheng HC
Front Oncol; 2020; 10():598192. PubMed ID: 33330092
[TBL] [Abstract][Full Text] [Related]
2. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
3. The roles of
Zheng HC; Xue H; Zhang CY; Shi KH; Zhang R
Front Genet; 2022; 13():1006636. PubMed ID: 36339000
[TBL] [Abstract][Full Text] [Related]
4. B‑cell translocation 1 gene inhibits cellular metastasis‑associated behavior in breast cancer.
Li W; Zou ST; Zhu R; Wan JM; Xu Y; Wu HR
Mol Med Rep; 2014 Jun; 9(6):2374-80. PubMed ID: 24714932
[TBL] [Abstract][Full Text] [Related]
5. BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers.
Zhao S; Chen SR; Yang XF; Shen DF; Takano Y; Su RJ; Zheng HC
Oncotarget; 2017 Jan; 8(5):7502-7520. PubMed ID: 27447746
[TBL] [Abstract][Full Text] [Related]
6. BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
Sheng SH; Zhao CM; Sun GG
Tumour Biol; 2014 Apr; 35(4):3317-26. PubMed ID: 24272202
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
8. BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma.
Li Y; Huo J; He J; Zhang Y; Ma X
Cancer Cell Int; 2020; 20():490. PubMed ID: 33041670
[TBL] [Abstract][Full Text] [Related]
9. BTG1 expression correlates with the pathogenesis and progression of ovarian carcinomas.
Zhao Y; Gou WF; Chen S; Takano Y; Xiu YL; Zheng HC
Int J Mol Sci; 2013 Sep; 14(10):19670-80. PubMed ID: 24084718
[TBL] [Abstract][Full Text] [Related]
10. BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker.
Lu YF; Sun GG; Liu Q; Yang CR; Cheng YJ
Int J Oncol; 2014 Oct; 45(4):1574-82. PubMed ID: 25017022
[TBL] [Abstract][Full Text] [Related]
11. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
12. Expression of B Cell Translocation Gene 1 Protein in Colon Carcinoma and its Clinical Significance.
Zhang J; Dong W
Recent Pat Anticancer Drug Discov; 2020; 15(1):78-85. PubMed ID: 31916520
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
14. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
15. Vimentin expression is associated with decreased survival in gastric cancer.
Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
[TBL] [Abstract][Full Text] [Related]
16. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
[TBL] [Abstract][Full Text] [Related]
17. miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1.
Su C; Huang DP; Liu JW; Liu WY; Cao YO
Oncol Lett; 2019 Sep; 18(3):2825-2834. PubMed ID: 31452761
[TBL] [Abstract][Full Text] [Related]
18. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
[TBL] [Abstract][Full Text] [Related]
19. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
20. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
